PROPHYLACTIC AND THERAPEUTIC INFLUENZA VACCINES, ANTIGENS, COMPOSITIONS AND METHODS

• US 20110059130A1
• Filed: 08/20/2008
• Published: 03/10/2011
• Est. Priority Date: 08/20/2007
• Status: Abandoned Application

• Current Assignee: Fraunhofer USA Inc. (Fraunhofer-Institut für Nachrichtentechnik HHI)
• Original Assignee: Fraunhofer USA Inc. (Fraunhofer-Institut für Nachrichtentechnik HHI)
• Inventors: Yusibov, Vidadi
• Application Number:
  US12/674,389
• Publication Number:
  US 20110059130A1
• Time in Patent Office: Days
• US Class Current: 424/210.1
• CPC Class Codes: A61K 39/0216 Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
• CPC Class Codes: A61P 31/16 for influenza or rhinoviruses
• CPC Class Codes: A61P 37/04 Immunostimulants
• CPC Class Codes: C12N 2760/16134 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and vaccines useful in prevention of infection by influenza virus. Provided are recombinant protein antigens, compositions, and methods for the production and use of such antigens and subunit vaccine compositions. In some embodiments, influenza antigens include hemagglutinin polypeptides neuraminidase polypeptides, and/or combinations thereof.

Claims

1-47. -47. (canceled)

48. An immunogenic composition comprising:

An influenza polypeptide antigen; and

a pharmaceutically acceptable excipient;

wherein the composition elicits an immune response upon administration to a subject.

49. The immunogenic composition of claim 48, wherein the influenza polypeptide antigen is plant-produced.

50. The immunogenic composition of claim 48, wherein the influenza polypeptide antigen is a hemagglutinin polypeptide.

51. The immunogenic composition of claim 48, wherein the influenza polypeptide antigen is a hemagglutinin polypeptide having a sequence selected from the group consisting of SEQ ID NOs.:

1-35, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107 and 109.

52. The immunogenic composition of claim 48, wherein the influenza polypeptide antigen is a neuraminidase polypeptide.

53. The immunogenic composition of claim 48 wherein the influenza polypeptide antigen is a neuraminidase polypeptide having a sequence selected from the group consisting of SEQ ID NOs.:

36-43.

54. The immunogenic composition of claim 48, wherein a single dose of the composition comprises no more than 100 μ

g of the influenza polypeptide antigen.

55. The immunogenic composition of claim 48, wherein a single dose of the composition comprises no more than 25 μ

g of the influenza polypeptide antigen.

56. The immunogenic composition of claim 48, wherein a single dose of the composition comprises no more than 5 μ

g of the influenza polypeptide antigen.

57. The immunogenic composition of claim 48, wherein a single dose of the subunit composition comprises no more than 1 μ

g of the influenza polypeptide antigen.

58. The immunogenic composition of claim 49, wherein the plant-produced influenza polypeptide antigen is present in a plant tissue or a plant extract.

59. A method for producing an influenza antigen polypeptide comprising:

a. administering a nucleic acid construct encoding an influenza antigen polypeptide into a plant cell; and

b. incubating the plant cell under conditions favorable for expression of the influenza antigen polypeptide;

thereby producing the influenza antigen polypeptide.

60. The method of claim 59, wherein the antigen is produced in a transgenic plant or in a plant transiently expressing the antigen.

61. The method of claim 59, wherein the antigen is expressed in the plant cell from a launch vector.

62. The method of claim 59, wherein expression of the antigen protein is under control of a viral promoter.

63. The method of claim 59, wherein the nucleic acid construct further comprises a vector nucleic acid sequence.

64. The method of claim 59, wherein the nucleic acid construct further comprises one or more sequences encoding viral proteins.

65. The method of claim 59, wherein the plant cell is selected from the group consisting of alfalfa cells, radish cells, mustard cells, mung bean cells, broccoli cells, watercress cells, soybean cells, wheat cells, sunflower cells, cabbage cells, clover cells, petunia cells, tomato cells, potato cells, tobacco cells, spinach cells and lentil cells.

66. The method of claim 59, wherein the plant cell is of a genus selected from the group consisting of the Brassica genus, the Nicotiana genus and the Petunia genus.

67. An isolated nucleic acid construct comprising nucleic acid sequence encoding an influenza antigen polypeptide, wherein the influenza antigen polypeptide comprises a sequence as set forth in any one of SEQ ID NOs:

1-43, 85, 87, 89, 91, 93, 95, 97, 99, 101, 103, 105, 107 and 109.